Why the rise of DNA testing is creating challenges — and an opportunity
By Noura Abul-Husn,
STAT
| 03. 29. 2023
Twenty years ago, virtually all people seeking genetic testing were individuals diagnosed with diseases possibly linked to their genetic makeup. Today, millions of people order genetic tests to learn about their ancestry, as well as to understand what their genes say about their future health.
This rapid growth has created what some might see as a big problem and others might see as an opportunity. The problem? There hasn’t been a corresponding increase in genetics education and training health care providers about it, meaning that many people are reaching out to health care providers who are ill-prepared to incorporate genetic test results into clinical practice. The opportunity? Results from genetic testing can help health care providers engage with their patients on a deeper level about personal health risks, promoting health, and preventing disease.
Help may be on the horizon. A team representing the National Society of Genetic Counselors, an association of thousands of genetic counselors across the country, published guidance in early January for genetic counselors and other health care providers to handle what the authors call elective genomic testing...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...